Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Bedford, Massachusetts
- Most recent report
- 8-K, filed Sep 25, 2026
- Incorporated
- Delaware
- Filings on record
- 623 filings
- On EDGAR
- CIK 1623526
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer, Smaller reporting company
Financials 8 of 30
News 8 of 85
Prospectuses and Registrations 8 of 27
- 424B5 Prospectus supplement for an offering Aug 3, 2026
- S-8 Registration statement for an employee plan Aug 3, 2026
- S-3ASR Automatic shelf registration Mar 18, 2026
- S-8 Registration statement for an employee plan Mar 16, 2026
- S-8 Registration statement for an employee plan Jul 9, 2025
- S-3 Shelf registration statement Jul 9, 2025
- S-8 Registration statement for an employee plan Mar 18, 2025
- S-3ASR Automatic shelf registration Oct 9, 2024
Proxies 8 of 18
- DEFA14A Extra proxy material Apr 22, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 22, 2026
- DEFA14A Extra proxy material Apr 22, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 22, 2025
- DEFA14A Extra proxy material Apr 23, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 23, 2024
- DEF 14A Proxy statement for a shareholder vote Sep 28, 2023
- PRE 14A Preliminary proxy statement Sep 18, 2023
Ownership 8 of 418
- 4 Insider reported a trade Sep 25, 2026
- 3 Insider reported their initial holding Sep 25, 2026
- 4 Insider reported a trade Sep 3, 2026
- 4 Insider reported a trade Aug 18, 2026
- 4 Insider reported a trade Aug 18, 2026
- 4 Insider reported a trade Aug 18, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 12, 2026
Other 8 of 45
- ARS Annual report sent to shareholders Apr 22, 2026
- EFFECT Notice that a registration became effective Jul 11, 2025
- CORRESP Reply to SEC staff Jul 9, 2025
- UPLOAD Comment letter from SEC staff Jun 30, 2025
- DRSLTR Jun 26, 2025
- DRS Draft registration statement, submitted confidentially Jun 26, 2025
- ARS Annual report sent to shareholders Apr 22, 2025
- EFFECT Notice that a registration became effective Jun 20, 2024
Everything here comes from Stoke Therapeutics, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.